Custom foot orthoses for chronic metatarsalgia: Study protocol for a participant- and assessor-blinded superiority randomized controlled trial
PLOS One · 2026
DOI: 10.1371/journal.pone.0340905 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift PLOS One, 2026. Verfasst von Eléna Payen Schalkens und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy, Université du Québec à Trois-Rivières, Trois-Rivières, Canada. Hauptthemen laut MEDLINE: Foot Orthoses, Metatarsalgia. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fonds de Recherche du Québec - Santé, Fondation de l'UQTR.
Abstract (Originalsprache)
Background
Chronic metatarsalgia (CM) causes significant pain and disability, affecting quality of life. Foot orthoses (FOs) including medially wedged designs with a metatarsal pad decrease excessive plantar pressure under the metatarsal heads, which is a suggested risk factor for developing CM. This FOs model may be effective in diminishing pain and improving function in these individuals. Thus, the objective of this trial will be to compare the effects of medially wedged FOs with a metatarsal pad and sham FOs on pain and foot function in individuals with CM. Methods/design This participant- and assessor-blinded superiority randomized controlled trial (RCT) with two parallel groups will be conducted in Trois-Rivières, Canada. Sixty-four participants with CM will be recruited from the Université du Québec à Trois-Rivières outpatient podiatry clinic and via social media invitations. They will be randomized into intervention (customized FOs) or control (sham FOs) groups and will be evaluated at baseline and after 6 and 12 weeks. The primary outcome will be: (1) mean pain during walking for the most painful foot during the past week. The secondary outcomes will be: (1) Foot Function Index, (2) Global rating of change and (3) the 5-level EQ-5D.
Discussion
Medially wedged FOs with a metatarsal pad are expected to provide a greater reduction in pain and improvement in foot function compared to sham FOs. This trial will help guide FOs prescription recommendations for managing foot pain in individuals with CM in the future.
Trial registration
ClinicalTrials.gov NCT06962475
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Anatomy, Université du Québec à Trois-Rivières, Trois-Rivières, Canada.
- Groupe de Recherche sur les Affections Neuromusculosquelettiques, Université du Québec à Trois-Rivières, Trois-Rivières, Canada.
- Departement of Chiropractic, Université du Québec à Trois-Rivières, Trois-Rivières, Canada.
- Department of Human Kinetics, Université du Québec à Trois-Rivières, Trois-Rivières, Canada.
ORCID-Profile: Eléna Payen Schalkens, Gabriel Moisan
Förderung
- Fonds de Recherche du Québec - Santé
- Fondation de l'UQTR
Zitieren
APA
Payen Schalkens, E., Acien, M., Marchand, A. A., Isabelle, P. L., Abboud, J., & Moisan, G. (2026). Custom foot orthoses for chronic metatarsalgia: Study protocol for a participant- and assessor-blinded superiority randomized controlled trial. PLOS One. https://doi.org/10.1371/journal.pone.0340905
Vancouver
Payen Schalkens E, Acien M, Marchand AA, Isabelle PL, Abboud J, Moisan G. Custom foot orthoses for chronic metatarsalgia: Study protocol for a participant- and assessor-blinded superiority randomized controlled trial. PLOS One. 2026. doi:10.1371/journal.pone.0340905
BibTeX
@article{PayenSchalkens2026,
author = {Payen Schalkens, Eléna and Acien, Maxime and Marchand, Andrée-Anne and Isabelle, Pier-Luc and Abboud, Jacques and Moisan, Gabriel},
title = {Custom foot orthoses for chronic metatarsalgia: Study protocol for a participant- and assessor-blinded superiority randomized controlled trial},
journal = {PLOS One},
year = {2026},
doi = {10.1371/journal.pone.0340905}
}
EUVIMED